Estimaciones de analistas de Wall Street para Lisata Therapeutics, Inc. (LSTA): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 0.97 |
| EV / EBITDA | -0.01 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $35.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.0M | $170000 |
| Coste de Ventas | $450266 | $372000 | $225000 | $65000 | $63000 | 0 | 0 | 0 | 0 | $146000 |
| Beneficio Bruto | $4.1M | -$372000 | -$225000 | -$65000 | -$63000 | 0 | 0 | 0 | $1.0M | $24000 |
| I+D | $15.1M | $17.1M | $7.6M | $13.5M | $9.3M | $17.6M | $43.5M | $12.7M | $11.3M | $7.9M |
| Generales y Administrativos | $12.8M | $11.8M | $9.4M | $9.3M | $9.9M | $11.5M | $14.1M | $13.0M | $12.1M | $10.4M |
| Gastos Operativos | $35.5M | $27.6M | $17.0M | $20.1M | $19.1M | $29.1M | $57.6M | $25.7M | $23.4M | $18.2M |
| Beneficio Operativo | -$31.3M | -$27.6M | -$17.0M | -$20.1M | -$19.1M | -$29.1M | -$57.6M | -$25.7M | -$22.4M | -$18.2M |
| EBITDA | -$29.0M | -$27.2M | -$16.8M | -$20.0M | -$19.1M | -$28.9M | -$56.6M | -$23.0M | -$20.6M | -$17.4M |
| Gastos por Intereses | $1.9M | $377768 | $5000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$31.3M | -$27.7M | -$16.2M | -$19.4M | -$19.0M | -$29.0M | -$56.7M | -$23.2M | -$20.8M | -$17.5M |
| Impuestos | $138038 | -$11.5M | -$1000 | 0 | -$10.9M | -$1.5M | -$2.5M | -$2.3M | -$798000 | -$962000 |
| Beneficio Neto | -$32.7M | $23.0M | -$16.2M | -$20.1M | -$8.2M | -$27.5M | -$54.2M | -$20.8M | -$20.0M | -$16.6M |
| BPA | $-74.81 | $38.43 | $-25.03 | $-29.20 | $-7.91 | $-7.45 | $-10.47 | $-2.58 | $-2.40 | $-1.91 |
| BPA Diluido | $-74.81 | $38.43 | $-25.03 | $-29.20 | $-7.91 | $-7.45 | $-10.47 | $-2.58 | $-2.40 | $-1.91 |
| Acciones en Circulación (Diluidas) | $436550 | $597933 | $645933 | $688333 | $1.0M | $3.7M | $5.2M | $8.1M | $8.3M | $8.7M |
Precio
| Precio | $1.47 |
| Capitalización | $13M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CASI · CLGN · CLSD · ENLV · KLTO · MTVA · NCNA
Explorar sector: Healthcare · Biotechnology
Más secciones de LSTA: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones